| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2011) |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| ATC: | V03AB08 |
| UNII: | M0KG633D4F |
| InChI Key | LPXPTNMVRIOKMN-UHFFFAOYSA-M |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | NNaO2 |
| Molecular Weight | 69.0 |
| AlogP | 0.14 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 0.0 |
| Polar Surface Area | 49.66 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 3.0 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Poisoning | 4 | D011041 | FDA |
| Acute Kidney Injury | 3 | D058186 | ClinicalTrials |
| Hypertension, Pulmonary | 2 | D006976 | ClinicalTrials |
| Diabetes Mellitus | 2 | D003920 | ClinicalTrials |
| Peripheral Arterial Disease | 2 | D058729 | ClinicalTrials |
| Anemia, Sickle Cell | 2 | D000755 | ClinicalTrials |
| Aging | 2 | D000375 | ClinicalTrials |
| Asthma | 2 | D001249 | ClinicalTrials |
| Renal Insufficiency, Chronic | 2 | D051436 | ClinicalTrials |
| Myocardial Infarction | 2 | D009203 | ClinicalTrials |
| Subarachnoid Hemorrhage | 2 | D013345 | ClinicalTrials |
| Heart Arrest | 2 | D006323 | ClinicalTrials |
| Hypertension, Pulmonary | 2 | D006976 | ClinicalTrials |
| Heart Failure | 2 | D006333 | ClinicalTrials |
| ST Elevation Myocardial Infarction | 2 | D000072657 | ClinicalTrials |
| Cystic Fibrosis | 1 | D003550 | ClinicalTrials |
| Malaria, Falciparum | 1 | D016778 | ClinicalTrials |
| Hypertension | 1 | D006973 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 78870 |
| ChEMBL | CHEMBL93268 |
| EPA CompTox | DTXSID0020941 |
| FDA SRS | M0KG633D4F |
| PharmGKB | PA166115361 |
| PubChem | 23668193 |
| SureChEMBL | SCHEMBL341 |